EsoCap AG reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis (EoE)
Great news! Our long-standing client EsoCap AG has unveiled impressive clinical data - another milestone on the road to groundbreaking advances in healthcare! We have proudly accompanied EsoCap as CFO partner since its inception and are thrilled to witness these...
Stille AB (publ) acquires Fehling Instruments
We advised Stille, a listed Swedish medtech company, in the acquisition of Fehling Instruments based in Germany in a joint mandate with our AICA network partner Evli Corporate Finance. Through the acquisition, Stille significantly broadens its product offering of...
Hoffmann & Partner AG is once again one of the best tax experts in Switzerland in 2024.
We are pleased that we are once again among the top tax experts & fiduciaries in Switzerland this year! For the fourth time, the market research institute Statista conducted a survey on behalf of BILANZ among several thousand industry professionals and clients in...
Adjustment of VAT rates as of 1.1.2024
As of 1.1.2024, the Swiss VAT rates will be adapted. Since this is not a reduction as was the case with the last changes five years ago, a potential tax risk arises if the billing is not correct. See here which points should be given special attention for the...
Hoffmann & Partner advised IWB in the acquisition of Kunz-Solartech GmbH.
The Basel-based energy services provider IWB is taking over the photovoltaic systems specialist Kunz-Solartech GmbH, headquartered in Brittnau. In line with its strategy, IWB further accelerates the growth of its renewable energy segment and strengthens its position...
Hoffmann & Partner advised Melisana AG in the sale of its brand BIOKOSMA to ebi-pharm ag.
As a pioneer of Swiss natural cosmetics, BIOKOSMA stands for contemporary care products with selected organic plant extracts since 1935. For strategic reasons, Melisana concentrates on the OTC sector in the future. The fact that the BIOKOSMA brand can be transferred...
Hoffmann & Partner advised Herbonis AG shareholders. Herbonis was sold to Innovad.
Innovad, a portfolio company of IK Partners and a leading provider of animal nutrition and health solutions, has acquired Switzerland based Herbonis AG. Herbonis AG provides a plant-based source of the metabolic active form of Vitamin D, a unique and highly technical...
Hoffmann & Partner expands its service offering and wins a first mandate with Kuros Biosciences
With the most recent additions to our partnership and board, Hoffmann & Partner has extended their offering to include executive CFO services for listed clients including clients pursuing a listing to an international stock exchange. Further the company now...
Changes in the national tax law destroy one of the biggest advantages for start-ups
Employee Stock Ownership Plans (ESOPs) in Switzerland Employee options were an attractive financial instrument before the tax law was changed per 01.01.2021. Prior to the changes employees could exercise their options when the fair value of share prices was still low...
Hoffmann & Partner M&A Insights: Allocation of the total equity value of a company to different share classes
Deriving the adequate values per preferred and common share is not straightforward. Dividing the total equity value or agreed company pre-money valuation in a financing transaction by the total amount of existing shares to receive the issue price is not correct if...